iBio
IBIO
#10074
Rank
HK$0.21 B
Marketcap
HK$9.34
Share price
-6.25%
Change (1 day)
-53.65%
Change (1 year)

iBio (IBIO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : HK$64.65 Million

According to iBio's latest financial reports the company's total liabilities are HK$64.65 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

iBio - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30HK$57.86 M-71.41%
2023-06-30HK$0.20 B-28.21%
2022-06-30HK$0.28 B-5.46%
2021-06-30HK$0.29 B2.36%
2020-06-30HK$0.29 B32.56%
2019-06-30HK$0.21 B4.01%
2018-06-30HK$0.21 B-0.12%
2017-06-30HK$0.21 B-1.08%
2016-06-30HK$0.21 B2084.22%
2015-06-30HK$9.78 M219.79%
2014-06-30HK$3.06 M-90.79%
2013-06-30HK$33.24 M19.16%
2012-06-30HK$27.89 M-49.79%
2011-06-30HK$55.55 M85.09%
2010-06-30HK$30.01 M614.47%
2009-06-30HK$4.2 M-94.47%
2008-06-30HK$76.03 M20.08%
2007-06-30HK$63.32 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Genocea Biosciences
GNCA
HK$0.20 B 217.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$6.83 B 10,477.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$883.85 B 1,367,016.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$1.68 B 2,503.99%๐Ÿ‡บ๐Ÿ‡ธ USA